Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease | PLOS ONE
µ Opioid Receptor Agonism for L-DOPA-Induced Dyskinesia in Parkinson's Disease | Journal of Neuroscience
Biomolecules | Free Full-Text | Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease | HTML
Levodopa-Induced Dyskinesia in Parkinson's Disease
Concomitant short‐ and long‐duration response to levodopa in the 6‐OHDA‐lesioned rat: a behavioural and molecular study - Marin - 2007 - European Journal of Neuroscience - Wiley Online Library
Levodopa-induced dyskinesias in Parkinson's disease - ScienceDirect
Dopamine dysregulation of movement control in L-DOPA-induced dyskinesia
Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa | PNAS
Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease | PLOS ONE
Enkephalin and dynorphin neuropeptides are differently correlated with locomotor hypersensitivity and levodopa-induced dyskinesia in parkinsonian rats - ScienceDirect
Concomitant shortâ•' and longâ•'duration response to levodopa in the 6â•'OHDAâ•'lesioned rat: a behavioural
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats. - Abstract - Europe PMC
Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa | PNAS
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap - ScienceDirect
Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa | PNAS
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap - The Lancet Neurology
Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease | PLOS ONE
Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap - ScienceDirect
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson's Disease | Pharmacological Reviews
l-DOPA-induced Dyskinesia is Associated with Regional Increase of Striatal Dynorphin Peptides as Elucidated by Imaging Mass Spectrometry - ScienceDirect
L-dopa-induced dyskinesia in Parkinson's disease patients | JEP
Imaging Mass Spectrometry Reveals Elevated Nigral Levels of Dynorphin Neuropeptides in L-DOPA-Induced Dyskinesia in Rat Model of Parkinson's Disease | PLOS ONE
